Contribute Try STAT+ Today
Trending:
Coronavirus
Morning Rounds
Health
First Opinion
First Opinion

Pharma and biotech companies: Don’t just merge, innovate

  • Patrick Skerrett

By Patrick Skerrett April 20, 2016

Reprints
Handshake merger
APStock

Editor’s note: This article was mistakenly published. It has been removed from the website.

About the Author Reprints

Patrick Skerrett

Patrick Skerrett

Editor, First Opinion

Patrick Skerrett edits First Opinion, First Opinion, STAT's perspective and opinion section, and is the host of the First Opinion Podcast.

Tags

Trending
vaccine silhouette
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and…
Comparing the Covid-19 vaccines developed by Pfizer, Moderna, and Johnson & Johnson
Pfizer vaccine vial close
CDC says people with history of severe allergic reactions…
CDC says people with history of severe allergic reactions can get Covid-19 vaccine
Pfizer freezer farm
The story of mRNA: How a once-dismissed idea became…
The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine…
Recommended
Moderna and Pfizer-BioNTech Covid-19 vaccines
Don’t let bureaucracy constrict the supply of Covid-19 vaccines
Don’t let bureaucracy constrict the supply of Covid-19 vaccines
Capitol reflection public health
Covid-19 could bring a new era of public health…
Covid-19 could bring a new era of public health leadership. But will it?
vaccines Johnson & Johnson
Using the new Johnson & Johnson Covid-19 vaccine to…
Using the new Johnson & Johnson Covid-19 vaccine to create equity and trust

More in First Opinion

Moderna and Pfizer-BioNTech Covid-19 vaccines
First Opinion

Don’t let bureaucracy constrict the supply of Covid-19 vaccines

By Andy Harris, Greg Murphy, and Mariannette Miller-Meeks

social media messages
First Opinion

Doctors on social media are being cyberbullied and sexually harassed. It’s time to change that

By Vineet Arora, Tricia Pendergrast, and Shikha Jain

Capitol reflection public health
First Opinion

Covid-19 could bring a new era of public health leadership. But will it?

By Marian W. Wentworth

vaccines Johnson & Johnson
First Opinion

Using the new Johnson & Johnson Covid-19 vaccine to create equity and trust

By Ruth R. Faden and Ruth A. Karron

convalescent plasma Covid-19
First Opinion

For early testing of convalescent plasma, we were ‘building the plane while we were flying it’

By Michael J. Joyner and Arturo Casadevall